Shire Adds to Genetic Disorder Drugs with U.S. Deal

08.01.2013 - British drugmaker Shire has agreed to buy Lotus Tissue Repair, a U.S. biotechnology company developing the first treatment for a rare genetic disorder that causes extremely fragile...